Susquehanna International Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Susquehanna International Group’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,400	Closed	-$207K	–	12120
2020 Q3	$207K	Sell	11,400 -9,100	-44%	-$129K	﹤0.01%	9397
2020 Q2	$281K	Sell	20,500 -17,400	-46%	-$268K	﹤0.01%	8466
2020 Q1	$542K	Sell	37,900 -22,900	-38%	-$376K	﹤0.01%	6764
2019 Q4	$1.03M	Sell	60,800 -36,300	-37%	-$675K	﹤0.01%	5465
2019 Q3	$1.49M	Buy	97,100 +28,100	+41%	+$599K	﹤0.01%	4828
2019 Q2	$1.62M	Sell	69,000 -37,700	-35%	-$931K	﹤0.01%	4597
2019 Q1	$3.02M	Sell	106,700 -5,100	-5%	-$149K	﹤0.01%	3113
2018 Q4	$3.37M	Sell	111,800 -16,900	-13%	-$474K	﹤0.01%	2774
2018 Q3	$4.51M	Buy	128,700 +100,700	+360%	+$3.05M	﹤0.01%	2816
2018 Q2	$664K	Buy	28,000 +2,700	+11%	+$64.5K	﹤0.01%	6237
2018 Q1	$648K	Buy	+25,300	New	+$545K	﹤0.01%	6124

Susquehanna International Group's AKCA Position: Q2 2020 in Review

Susquehanna International Group sold out of Akcea Therapeutics Inc (AKCA) in Q2 2020, closing a stake of 33,430 shares — an estimated $516K sold.

Susquehanna International Group first reported a position in AKCA in Q2 2019 and held it in 3 quarters. The position peaked at $1.03M in Q4 2019. 84 funds tracked by Wall St. Rank hold AKCA as of Q2 2020.

Susquehanna International Group reported no remaining Akcea Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
Susquehanna International Group sold 33,430 Akcea Therapeutics Inc shares in Q2 2020, an estimated $516K.
Susquehanna International Group first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 3 quarters.
Susquehanna International Group's Akcea Therapeutics Inc position peaked at $1.03M in Q4 2019.
84 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.